Navigating the complex landscape of regulatory affairs and compliance is crucial for the successful development, approval, and commercialization of therapies in gastroenterology and hepatology. This track at the Global Gastroenterology, Liver Diseases & Hepatology Conference & Industry Expo brings together regulatory experts, industry leaders, clinicians, and innovators to explore the latest standards, frameworks, and best practices.
Key topics include:
Understanding global regulatory pathways for drugs, biologics, and medical devices
Compliance with FDA, EMA, and international guidelines
Ethical considerations in clinical trials and research
Risk management and pharmacovigilance strategies
Navigating approval processes and accelerated pathways
Opportunities for industry partnerships and investment in compliant innovation
Attendees will gain actionable insights into ensuring regulatory compliance while fostering innovation, investment, and collaborative growth in GI and liver disease therapeutics.
Sub Topics: Regulatory Frameworks in GI, FDA Compliance, EMA Guidelines, Clinical Trial Regulations, Drug Approval Pathways, Biologics Approval, Medical Device Regulations, International Regulatory Standards, Pharmacovigilance Strategies, Risk Management Plans, Post-Market Surveillance, Compliance Audits, Regulatory Documentation, Labeling & Packaging Compliance, Data Integrity in Trials, Ethical Considerations, Patient Safety Protocols, Good Clinical Practice (GCP), Good Laboratory Practice (GLP), Good Manufacturing Practice (GMP), Regulatory Intelligence, Market Authorization Processes, Accelerated Approval Pathways, Orphan Drug Regulations, Digital Health Compliance, AI in Healthcare Regulations, Telemedicine Regulations, Cross-Border Compliance, Health Authority Interactions, Clinical Study Reporting, Regulatory Submission Strategies, Quality Management Systems, Inspection Readiness, Regulatory Affairs Training, Investigator Compliance, Contract Research Organization Compliance, Safety Reporting Guidelines, Adverse Event Management, Risk-Based Monitoring, Regulatory Policy Updates, International Harmonization, Compliance in Nutraceuticals, Regulatory Technology Innovations, Medical Writing for Compliance, Ethical Committee Approvals, Post-Approval Commitments, Labeling Changes, Market Withdrawal Procedures, Strategic Regulatory Planning, Regulatory Affairs in Liver Therapies, Regulatory Affairs in GI Innovations, Innovation-Compliant Integration
Keynote Points:
Very large and growing global patient population
Chronic symptom management requiring long-term solutions
Strong demand for OTC medications, probiotics, and dietary products
Expansion of low-FODMAP, personalized nutrition, and medical foods
Rising adoption of digital IBS management and telehealth platforms
High consumer engagement and self-care spending
Cross-selling opportunities across pharma, wellness, and lifestyle brands
Benefits:
Massive addressable market with recurring consumer demand
Multiple revenue channels: prescription, OTC, nutrition, and digital health
High brand loyalty driven by symptom relief and patient trust
Attractive ROI due to scalable, non-invasive treatment models
Ideal segment for subscription-based and direct-to-consumer strategies
Alignment with preventive, holistic, and patient-centric GI care trends
WhatsApp: https://wa.me/+971551792927
Email: info-ucg@utilitarianconferences.com